Hugel, Inc. (KOSDAQ:145020)
South Korea · Delayed Price · Currency is KRW 225,500
-2,000 (-0.88%)
Dec 10, 2025, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 2.44 trillion as of December 10, 2025. Its market cap has decreased by -15.92% in one year.
Market Cap
2.44T
Enterprise Value
2.02T
Revenue
404.19B
Ranking
n/a
PE Ratio
17.72
Stock Price
225,500.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 2.44T, an increase of 340.69%. That is a compound annual growth rate of 16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 2.44T | -21.15% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | 2.35T | 75.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |